newsfilter
← Latest News
GlobeNewswire·

Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings

GAINESVILLE, Ga., June 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (("Recro", NASDAQ:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing